Matthew Hammond

Founder at RESEARCH ALLIANCE CORP. II

37 year

Finance

Health Technology

Consumer Services

Profile

Matthew Hammond is the founder of Therapeutics Acquisition Corp., founded in 2020, where the title held was Chief Financial Officer, Secretary & Director from 2020 to 2021.
Dr. Hammond is the founder of Research Alliance Corp.
II, founded in 2020, holding the titles of Director & Chief Investment Officer since 2020.
Current jobs include Chief Executive Officer & Director at Research Alliance Corp.
III starting in 2026, Chief Executive Officer & Director at Research Alliance Corp.
IV starting in 2026, Chief Financial Officer & Director at Indefinite Integral, Inc., Director at Cerebral Therapeutics, Inc., Director at Kira Pharmaceuticals (US) LLC, Director at Ambros Therapeutics, Inc. starting in 2025, Principal at RA Capital Management LP (Private Equity) since 2014, and Partner at RA Capital Management LP since 2024.
Former jobs include Director at DTx Pharma, Inc. from 2021 to 2023, Director at Jnana Therapeutics, Inc. from 2021 to 2024, Director at Forge Biologics, Inc. from 2021 to 2023, and Member-Supervisory Board at Emergence Therapeutics AG from 2022 to 2023.
Education history includes an MBA and a doctorate from the University of Connecticut, both conferred in 2014, and an undergraduate degree from the University of Georgia conferred in 2010.

Matthew Hammond active positions

Companies	Position	Start
RESEARCH ALLIANCE CORP. II	Founder	16/07/2020
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Analyst-Equity	30/11/2014
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Private Equity Investor	30/11/2014
Cerebral Therapeutics, Inc. Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases	Director/Board Member	-
Indefinite Integral, Inc. Indefinite Integral, Inc. Financial ConglomeratesFinance Provides financial services	Director of Finance/CFO	-
Kira Pharmaceuticals (US) LLC Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Develops transformative therapies for people with complement-mediated diseases	Director/Board Member	-

All active positions of Matthew Hammond

Former positions of Matthew Hammond

Companies	Position	End
Jnana Therapeutics, Inc. Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines	Director/Board Member	31/08/2024
Forge Biologics, Inc. Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company	Director/Board Member	30/11/2023
Emergence Therapeutics AG Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs	Director/Board Member	31/07/2023
░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░ ░░░░	░░░░░░░	░░░░░░░░░░

See the detail of Matthew Hammond's experience

Training of Matthew Hammond

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Hammond's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
RA Capital Management LP RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization.	Finance
University of Connecticut University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Georgia University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DTx Pharma, Inc. DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications	Health Technology
Jnana Therapeutics, Inc. Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines	Health Technology
Indefinite Integral, Inc. Indefinite Integral, Inc. Financial ConglomeratesFinance Provides financial services	Finance
Cerebral Therapeutics, Inc. Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops neurological therapeutics for uncontrolled neurological diseases	Commercial Services
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Finance
Emergence Therapeutics AG Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs	Health Technology
Therapeutics Acquisition Corp. Therapeutics Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Forge Biologics, Inc. Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company	Health Technology
Kira Pharmaceuticals (US) LLC Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Develops transformative therapies for people with complement-mediated diseases	Health Technology
Research Alliance Corp. II Research Alliance Corp. II Financial ConglomeratesFinance Operates as a blank check company	Finance